Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorb, Acino, ACTEMRA, alemtuzumab, Argentina, ARZERRA, Asia, attached, auto, banc, bankruptcy, BART, BBB, benchmark, Biotech, bowel, Brian, Cal, catch, chart, Chugai, circumstance, cladribine, competitor, Consent, conservative, corroborated, CV, declaratory, Deutschland, dispersion, EC, efalizumab, emergence, en, exemplary, EXTAVIA, Facet, FDIC, fifteen, fingolimod, franchise, FSPNo, graph, herewith, hierarchy, highest, highlighted, Hoechst, Hungary, ICC, immaterial, immunotherapy, incidence, inquiry, instability, invalid, invalidation, kroner, lastly, Lehman, lifecycle, LINGO, MAb, mediation, mistakenly, mondoGen, mortgage, MSCRG, nonrecurring, occupancy, override, par, parcel, physical, pivotal, Posner, pre, Progenitor, publish, published, Qualitative, RAPTIVA, recurring, rehearing, reorganization, revocation, revoked, RIXUTAN, roll, Sanofi, sense, slated, speak, split, spot, spring, spun, survey, swap, Tex, tightening, TLGP, tocilizumab, TREANDA, UK, ulcerative, unadjusted, unchanged, unobservable, upgraded, vi, waged, Weston, white, wrote, Zimmer
Removed:
acceleration, accepting, activated, added, Adelman, adhesion, administering, advanced, affiliated, AFFIRM, aggressive, al, ANDA, andRule, animal, announcement, anti, appeal, applicant, applying, argument, arrange, artificially, Authorisation, avoiding, Berlex, bioavailability, bioequivalence, bloodstream, bone, Boston, Brown, Burt, campaign, captioned, cascade, CDAI, choose, close, closely, collection, comparative, comparing, comprise, confirming, conspired, constrain, convey, copy, coupon, Creation, CRIPTO, decedent, declared, deduction, demanded, died, dilution, Dr, Dunn, earning, ENCORE, enhancing, enlarging, entitle, entrepreneurial, essential, evaluated, exchanged, expressed, Faheem, forfeited, formation, formulation, fulfilled, fusion, GAAP, gadolinium, governing, Grill, guarantor, Hasnain, Hillerod, Hybridon, hyperintense, identity, idle, immunomodulatory, indenture, induction, inflating, inhibit, inhibiting, insulation, internet, intervene, intervention, John, Judge, judged, Keller, Kellogg, leader, length, lieu, Lobel, lymphoproliferative, lymphotoxin, Lynch, MAA, Maine, mantle, marrow, McDermott, MDS, Merrill, migrating, migration, misleading, Nassau, negligence, neublastin, neuropathic, NIMO, noncompliance, notifying, observation, observational, observed, opposed, organ, outplacement, page, patchwork, peripheral, personal, personally, phototherapy, physiology, Pillsbury, pioneer, plaque, play, pleaded, power, precursor, predominantly, prevented, priced, principle, proceed, prohibited, promote, promulgated, proper, prospective, purported, purportedly, radioimmunotherapy, randomized, Rastetter, recommend, reconsidered, redeem, redemption, referenced, regenerate, rejection, relied, repatriate, repatriation, representation, rescue, restarted, retreatment, retrospective, role, salary, scan, seal, sensory, SENTINEL, seq, shorten, signaling, solicited, solid, soluble, sought, spanning, specificity, stem, steroid, Street, subordinated, substitute, suffering, thereunder, tissue, TMC, today, tolerated, trained, transfer, transformed, transitional, unrepatriated, unsealed, unspecified, USP, Washington, Winthrop
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 EX-4.4 Amendment No. 2 to Amended and Restated Rights Agreement Between Biogen Idec and Mellon Investor Services LLC Dated As of January 22, 2009.
- 10.19 EX-10.19 Amendment to Biogen Idec Inc. 2008 Omnibus Equity Plan Dated October 13, 2008
- 10.25 EX-10.25 Amendment to Biogen Idec Inc. 2006 Non-employee Directors Equity Plan Dated October 13, 2008
- 10.30 EX-10.30 Amendment to Biogen Idec Inc. 2005 Omnibus Equity Plan Dated October 13, 2008
- 10.34 EX-10.34 Amendment to Biogen Idec Inc. 2003 Omnibus Equity Plan Dated October 13, 2008
- 10.45 EX-10.45 Amendment to Biogen, Inc. 1985 Non-qualified Stock Option Plan Dated October 13, 2008
- 10.51 EX-10.51 Biogen Idec Inc. Executive Severance Policy - U.S. Executive Vice President, As Amended Effective October 13, 2008.
- 10.52 EX-10.52 Biogen Idec Inc. Executive Severance Policy - International Executive Vice President, As Amended Effective October 13, 2008.
- 10.53 EX-10.53 Biogen Idec Inc. Executive Severance Policy - U.S. Senior Vice President, As Amended Effective October 13, 2008.
- 10.54 EX-10.54 Biogen Idec Inc. Executive Severance Policy - International Senior Vice President, As Amended Effective October 13, 2008.
- 10.59 EX-10.59 Second Amendment to Employment Agreement Between Biogen Idec and James C. Mullen Dated As of December 4, 2008
- 10.61 EX-10.61 Employment Agreement Between Biogen Idec Management Services GMBH and Hans Peter Hasler Dated October 15, 2008.
- 10.63 EX-10.63 First Amendment to Employment Agreement Between Biogen Idec and Cecil B. Pickett Dated As of October 28, 2008
- 10.66 EX-10.66 First Amendment to Employment Agreement Between Biogen Idec and Craig E. Schneier Dated October 8, 2008
- 21.1 EX-21.1 Subsidiaries
- 23.1 EX-23.1 Consent of Pricewaterhousecoopers LLP - an Independent Registered Public Accounting Firm
- 31.1 EX-31.1 Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 EX-31.2 Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 EX-32.1 Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
BIIB similar filings
Filing view
External links